Cell Cycle Proteins Predict Recurrence in Stage II and III Colon Cancer
Open Access
- 4 February 2012
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 19 (S3) , 682-692
Abstract
Purpose To investigate the prognostic value of multiple cell cycle-associated proteins in a large series of stage II and III colon cancers.Keywords
This publication has 49 references indexed in Scilit:
- Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancerJournal of Clinical Pathology, 2006
- Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?Journal of Clinical Oncology, 2004
- Tissue microarraysBioTechniques, 2004
- Activation and activities of the p53 tumour suppressor proteinBritish Journal of Cancer, 2001
- The Hallmarks of CancerCell, 2000
- Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon CancerJournal of Clinical Oncology, 1999
- p53, guardian of the genomeNature, 1992
- p53 Mutations in Human CancersScience, 1991
- p53 mutations in colorectal cancer.Proceedings of the National Academy of Sciences, 1990
- TNM Classification of Malignant Tumours1987